BRCA1 and breast neoplasm: The co-occurrence of BRCA1 loss and TAZ gain may represent a genetic feature of basal-like breast tumors and may provide a rationale for the aggressiveness of BRCA1 mutated tumors, where inactivation of the BRCA1 tumor suppressor may also have the effect of activating the TAZ oncogenic program.